Medication-adherent first-episode psychosis patients also relapse: Why?

Canadian Journal of Psychiatry

Volumn 57, Issue 2, 2012, Pages 78-84

  Levy, Emmanuelle ^a   Pawliuk, Nicole ^b   Joober, Ridha ^a   Abadi, Sherezad ^b   Malla, Ashok ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

First episode psychosis; Medication adherence; Relapse

Indexed keywords

OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADOLESCENT; ADULT; AFFECTIVE PSYCHOSIS; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RELAPSE; REMISSION; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 84864566874     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371205700204     Document Type: Article

References (31)

1. Robinson D, Woerner M, Alvir J, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56:241-247. (Pubitemid 29125132)
2. Larsen TK, Moe LC, Vibe-Hansen L, et al. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res. 2000;45:1-9.
3. Malla A, Norman R, Bechard-Evans L, et al. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychol Med. 2008;38:1585-1593.
4. Rabiner CJ, Wegner JT, Kane JM. Outcome study of 1st-episode psychosis. 1. Relapse rates after 1 year. Am J Psychiatry. 1986;143:1155-1158. (Pubitemid 16041886)
5. Ucok A, Polat A, Cakir S, et al. One year outcome in first episode schizophrenia - predictors of relapse. Eur Arch Psy Clin N. 2006;256:37-43. (Pubitemid 43288242)
6. Wiersma D, Nienhuis FJ, Slooff CJ, et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull. 1998;24:75-85. (Pubitemid 28128490)
7. Petersen L, Nordentoft M, Jeppesen P, et al. Improving 1-year outcome in first-episode psychosis: OPUS trial. Br J Psychiatry Suppl. 2005;48:S98-S103. (Pubitemid 41139673)
8. Leucht S, Barnes T, Kissling W, et al. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry. 2003;160:1209-1222. (Pubitemid 41070936)
9. Wade D, Harrigan S, Edwards J, et al. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry. 2006;189:229-234. (Pubitemid 44343467)
10. First M, Spitzer R, Gibbon M, et al. Stuctured Clinical Interview for DSM-IV-TR axis 1 disorders, research version, patient edition. New York (NY): Biometrics Research, New York State Psychiatric Institute; 2002.
11. Cassidy C, Rabinovitch M, Joober R, et al. 117-Is any one method of measuring medication adherence in first-episode psychosis better than others? Schizophr Res. 2008;98(Suppl 1):81.
12. Cassidy C, Rabinovitch M, Schmitz N, et al. A comparison study of multiple measures of adherence to antipsychotic medications in first episode psychosis. J Clin Psychopharmacol. 2010;30:64-67.
13. Andreasen N. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City (IA): University of Iowa; 1984.
14. Andreasen N. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl. 1989;7:S49-S58.
15. Craig TK, Garety P, Power P, et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ. 2004;329(7474):1067.
16. Linszen DH, Dingemans PM, Lenior ME, et al. Relapse criteria in schizophrenic disorders: different perspectives. Psychiatry Res. 1994;54:273-281.
17. Csernansky J, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med. 2002;346:16-22.
18. van Mastrigt S, Addington J. Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci. 2002;27:92-101.
19. Cannon-Spoor H, Potkin S, Wyatt R. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8:470-484.
20. Haas GL, Sweeney JA. Premorbid and onset features of first-episode schizophrenia. Schizophr Bull. 1992;18:373-386.
21. Larsen T, McGlashan T, Moe L. First-episode schizophrenia: I. Early course parameters. Schizophr Bull. 1996;22:241-256. (Pubitemid 26174572)
22. Larsen T, Friis S, Haahr U, et al. Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br J Psychiatry. 2004;185:108-115. (Pubitemid 39061453)
23. Malla A, Norman R, Schmitz N, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med. 2006;36:649-658.
24. Norman R, Malla A, Verdi M, et al. Understanding delay in treatment for first-episode psychosis. Psychol Med. 2004;34:255-266. (Pubitemid 38239633)
25. Malla AK, Norman RMG, Manchanda R, et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res. 2002;54:231-242. (Pubitemid 34304216)
26. SPSS Inc. SPSS, version 15.0 [software]. Chicago (IL): SPSS Inc; 2006.
27. Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull. 2005;31:650-671. (Pubitemid 41253317)
28. Regier D, Farmer M, Rae D, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J Am Med Assoc. 1990;264:2511-2518.
29. Linszen D, Dingemans P, Nugter M, et al. Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophr Bull. 1997;23:119-130. (Pubitemid 27087912)
30. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51:273-279. (Pubitemid 24127299)
31. Hides L, Dawe S, Kavanagh D, et al. Psychotic symptom and cannabis relapse in recent-onset psychosis. Br J Psychiatry. 2006;189:137-143. (Pubitemid 44231272)